UnitedHealthcare
Iressa (gefitinib)
Drugs for Cancer : Drugs for Cancer
  • Orally administered anticancer medication.
  • NSCLC EGFR Mutated:
    Duration: 12 Month(s)
    Documented Diagnosis: Yes
    Medical Test Required: Yes
    Specialty Pharmacy Provider(s): Accredo Health Group, Inc.
    Reauthorization Required: Yes
    Duration of Reauthorization: = 12 month(s)

  • Prior Authorization: NSCLC EGFR Mutated:
    Documented Diagnosis: Yes
    Medical Test Required: Yes
    Duration: 12 Month(s)
    Reauthorization Required: Yes